Robuta

https://pubmed.ncbi.nlm.nih.gov/32641104/
Baseline PS is a strong prognostic factor when interpreting the efficacy of 5-FU and oxaliplatin-based therapy of pancreatic cancer after progression on...
meta analysisoverall survivalpancreatic cancerexaminingpatients
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1130680/full
AbstractBackground: For metastatic prostate cancer (mPCa), radical prostatectomy (RP) and radiation therapy (RT) may improve overall survival (OS) and cancer...
overall survivalfrontierscancerspecificimproved
https://pubmed.ncbi.nlm.nih.gov/26880040/
Beclin-1 is a key regulator of autophagy and has been suggested to be involved in the development of drug resistance in multiple myeloma (MM). We analyzed the...
overall survivallowexpressionimprovedpatients
https://www.ajmc.com/view/elderly-patients-with-dlbcl-face-poor-overall-survival-high-costs-with-r-gemox-treatment
Treatment with R-GemOx was associated with significant health care resource utilization, high costs surrounding treatment, and low overall survival in elderly...
overall survivalolderpatientsdlbclface
https://pubmed.ncbi.nlm.nih.gov/28144152/
OS increased in RCC and mRCC patients in Norway between 2002 and 2011 following introduction of targeted therapies.
renal cell carcinomaoverall survivalintroductiontargeted